Clinical Trials

RedHill Biopharma Ltd. , a specialty biopharmaceutical company, announced preliminary top-line data from the 475-patient global Phase 2/3 study with opaganib (ABC294640) in hospitalized patients with severe COVID-19 pneumonia. Preliminary top-line data showed that the study did not meet its...

Karen Ooms at Quanticate explains why clinical trial data alone is not enough to truly understand a drug’s effectiveness and argues that real-world data (RWD) is the key to filling the gap. Randomized clinical trials have long been a...

Medrio, Inc. a leading provider of decentralized and eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets and PHASTAR, a global specialist biometrics clinical research organization (CRO) offering industry-leading data management, data science, statistical consulting, and...

Dutch blockchain companies LTO Network and Sphereon have partnered with Triall, experts in the realm of blockchain and clinical research, to deliver the first COVID-19 clinical trials anchored to blockchain technology. In a critical first step towards advancing the digital...

Reliance Life Sciences has obtained approval from the Drugs Controller General of India (DCGI) to carry out a Phase I clinical trial of its Covid-19 vaccine with some conditions. This trial will assess the safety, tolerability and immunogenicity of the...

Sorrento Therapeutics, Inc. announced the start of enrollment in its Phase 2 efficacy study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC™) for patients suffering from COVID-19-induced acute respiratory distress (ARD) or acute respiratory distress syndrome (ARDS) in Brazil....

NRx Pharmaceuticals has reported additional data from Phase IIb/III clinical trial where its drug, Zyesami (aviptadil), offered a rise in blood oxygen within a day in critical Covid-19 patients with acute respiratory failure. Zyesami is a synthetic form of vasoactive...